122 related articles for article (PubMed ID: 6777634)
1. Absorption of percutaneous oestradiol in postmenopausal women.
Sitruk-Ware R; de Lignieres B; Basdevant A; Mauvais-Jarvis P
Maturitas; 1980 Oct; 2(3):207-11. PubMed ID: 6777634
[TBL] [Abstract][Full Text] [Related]
2. Post-menopausal concentrations of plasma oestradiol, oestrone, FSH and LH and of total urinary oestradiol and oestrone after a single sublingual dose of oestradiol-17 beta.
Fiet J; Hermano M; Witte J; Villette JM; Haimart M; Gourmel B; Tabuteau F; Rouffy J; Dreux C
Acta Endocrinol (Copenh); 1982 Sep; 101(1):93-7. PubMed ID: 6812348
[TBL] [Abstract][Full Text] [Related]
3. Plasma oestrone, oestradiol and gonadotrophin concentrations in postmenopausal patients treated with oestradiol or with a combination of oestradiol and oestriol.
Sipinen S
Ann Clin Res; 1979 Oct; 11(5):172-8. PubMed ID: 121048
[TBL] [Abstract][Full Text] [Related]
4. Endocrine and clinical effects of estradiol and testosterone pellets used in long-term replacement therapy.
Kapetanakis E; Dmowski WP; Auletta F; Scommegna A
Int J Gynaecol Obstet; 1982 Oct; 20(5):387-99. PubMed ID: 6128271
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic studies on low dose estradiol 17 beta administered orally to postmenopausal women.
Sipinen S; Lähteenmäki P; Luukkainen T
Acta Obstet Gynecol Scand; 1980; 59(2):149-53. PubMed ID: 6773291
[TBL] [Abstract][Full Text] [Related]
6. Influence of conjugated oestrogens on circulating oestradiol, oestrone, LH, FSH and prolactin levels in postmenopausal women.
Luisi M; Franchi F; Argenio GF; Barletta D; Romano MR; Bernini GP; Gasperi M; Sgrilli R
Int J Tissue React; 1981 Jun; 3(2):77-81. PubMed ID: 6799393
[TBL] [Abstract][Full Text] [Related]
7. Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration.
De Lignieres B; Basdevant A; Thomas G; Thalabard JC; Mercier-Bodard C; Conard J; Guyene TT; Mairon N; Corvol P; Guy-Grand B
J Clin Endocrinol Metab; 1986 Mar; 62(3):536-41. PubMed ID: 3080464
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamic effects of vaginal oestradiol administration from silastic rings in post-menopausal women.
Englund DE; Victor A; Johansson ED
Maturitas; 1981 Aug; 3(2):125-33. PubMed ID: 6793811
[TBL] [Abstract][Full Text] [Related]
9. Serum FSH, LH and oestrone levels in postmenopausal patients on oestrogen therapy.
Larsson-Cohn U; Johansson ED; Kågedal B; Wallentin L
Br J Obstet Gynaecol; 1978 May; 85(5):367-72. PubMed ID: 646971
[TBL] [Abstract][Full Text] [Related]
10. Oestrogens, gonadotrophins and SHBG during oral and cutaneous administration of oestradiol-17 beta to menopausal women.
Fåhraeus L; Larsson-Cohn U
Acta Endocrinol (Copenh); 1982 Dec; 101(4):592-6. PubMed ID: 6818806
[TBL] [Abstract][Full Text] [Related]
11. The absorption and metabolism of oral oestradiol, oestrone and oestriol.
Townsend PT; Dyer GI; Young O; Whitehead MI; Collins WP
Br J Obstet Gynaecol; 1981 Aug; 88(8):846-52. PubMed ID: 6789863
[TBL] [Abstract][Full Text] [Related]
12. Vaginal absorption of estrone and 17beta-estradiol.
Schiff I; Tulchinsky D; Ryan KJ
Fertil Steril; 1977 Oct; 28(10):1063-6. PubMed ID: 908445
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.
Rannevik G; Jeppsson S; Johnell O; Bjerre B; Laurell-Borulf Y; Svanberg L
Maturitas; 1995 Feb; 21(2):103-13. PubMed ID: 7752947
[TBL] [Abstract][Full Text] [Related]
14. Endometrium and plasma hormone profile in the peri-menopause and post-menopause.
Trévoux R; De Brux J; Castanier M; Nahoul K; Soule JP; Scholler R
Maturitas; 1986 Dec; 8(4):309-26. PubMed ID: 3106758
[TBL] [Abstract][Full Text] [Related]
15. Subdermal estradiol pellets following hysterectomy and oophorectomy. Effect upon serum estrone, estradiol, luteinizing hormone, follicle-stimulating hormone, corticosteroid binding globulin-binding capacity, testosterone-estradiol binding globulin-binding capacity, lipids, and hot flushes.
Lobo RA; March CM; Goebelsmann U; Krauss RM; Mishell DR
Am J Obstet Gynecol; 1980 Nov; 138(6):714-9. PubMed ID: 6776814
[TBL] [Abstract][Full Text] [Related]
16. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of oestrone, oestradiol and gonadotrophins in postmenopausal women after oral and vaginal administration of conjugated equine oestrogens (Premarin).
Englund DE; Johansson ED
Br J Obstet Gynaecol; 1978 Dec; 85(12):957-64. PubMed ID: 216384
[TBL] [Abstract][Full Text] [Related]
18. Laboratory criteria for menopause in women using oral contraceptives.
Creinin MD
Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618
[TBL] [Abstract][Full Text] [Related]
19. Influence of thyrotropin-releasing hormone on the postmenopausal female.
Lee SG; Lundy LE; Kashef M; Dorn J
Obstet Gynecol; 1975 Jan; 45(1):25-6. PubMed ID: 803307
[TBL] [Abstract][Full Text] [Related]
20. Serum concentrations of 17beta-estradiol and estrone after multiple-dose administration of percutaneous estradiol gel in symptomatic menopausal women.
Brennan JJ; Lu Z; Whitman M; Stafiniak P; van der Hoop RG
Ther Drug Monit; 2001 Apr; 23(2):134-8. PubMed ID: 11294513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
